Blog Profile / Prescriptions
| URL : | http://prescriptions.blogs.nytimes.com/ | |
|---|---|---|
| Filed Under: | Medical / Pharmaceutical | |
| Posts on Regator: | 143 | |
| Posts / Week: | 1.1 | |
| Archived Since: | November 22, 2010 | |
Blog Post Archive
A Note to Readers of This Blog
The Times is discontinuing the Prescriptions blog.
Doctors Refer More Patients to Specialists
A new study finds that primary care doctors are referring patients to other doctors at double the rate of a decade ago. The reasons are unclear but the researchers say the practice is driving up health care costs.
New Questions Raised About Tamiflu's Effectiveness
A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.
Walgreen Girds for Fight Over Customers
Walgreen to introduce a national plan it hopes will minimize customer disruption from its contract battle with its pharmacy benefits manager, Express Scripts.
Final Rules Set for Insurers on Spending Ratios
The industry did not get an exemption for brokers' fees under the regulations for how much of a customer's premium must be spent on medical care.
Labor Department Seeks Tougher Rules on 'Multiple-Employer' Plans
The federal agency says it wants more authority to crack down on insurance plans that take advantage of small businesses and their employees.
A Look at Berwick's Tenure as Medicare Chief
Health Affairs offers a retrospective on Dr. Donald Berwick, who is leaving his post as head of the Centers for Medicare and Medicaid Services.
States Receive Health Care Grants
The Department of Health and Human Services issued the funds as part of the planning to set up exchanges for health insurance coverage.
F.D.A. Revokes Approval of Avastin for Breast Cancer
The Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for breast cancer after concluding that it "has not been shown to be safe and effective for that use."
Amgen Agreement on Anemia Drug
Moving to protect a lucrative monopoly against impending competition, Amgen has reached an agreement that will preserve its status as the main supplier of anemia drugs to one of the nation's two large kidney dialysis chains.
F.D.A. Is Urged to Issue More Alerts About Drug Risks
Articles in a medical journal say the Food and Drug Administration needs to offer doctors and consumers more guidance about potentially dangerous prescriptions.
Retail Health Care Competition Heats Up
Wal-Mart has sent letters seeking new partnerships with medical providers, in an effort to catch up to some of its competitors' retail health clinics.
Agency Restores Doctor Discipline Files - With a Catch
Use of the database now requires a promise that individual doctors would not be identified through matching the information with other publicly available files.
Amylin and Eli Lilly Part Ways Over Diabetes Drug
The smaller company objected to Eli Lilly's work with what it considered a competing diabetes drug.
Doctor Groups Seem Less Wary of Medicare Changes
Regulations related to accountable care organizations include fewer benchmarks and provide upfront incentives for some groups.
New Melanoma Screening Device Approved
The Food and Drug Administration will allow the device to be used by dermatologists in the hopes of detecting the skin cancer early.
Prostate Cancer Drug Shows Promise in Study
Medivation announced that a late-stage clinical trial was so successful that it was stopped early to provide the drug to all participants.
Study: Few Hospitals Qualify for Digital Funds
About 10 percent of the nation's hospitals meet criteria that would enable them to qualify for extra payments under Medicare and Medicaid.
Vertex Bests Merck in New Hepatitis C Drug Sales
The new treatments were approved only last spring.
Study: Yaz Has Higher Risks of Blood Clots
A new Denmark study shows that a newer generation of birth control pills poses more danger of venous thromboembolism.